World HLTV Day: Exploring the perspective of patients, clinicians and scientists

Today BMJ STI honours World Human T-cell Leukaemia Virus (HTLV) Day. More than 40 years ago, before the discovery of HIV, Bob Gallo and his team discovered HTLV-1, an oncovirus and the first recognised human retrovirus. An estimated 5-10 million individuals have been exposed to infection with HTLV type-1 globally, with specific hyperendemic regions (1). […]

Read More…

From the Editor’s Desk – Highlights of the September Issue of Sexually Transmitted Infections

Editor’s choice: Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May–July 2019, UK Why does it matter? Investigators used an online community survey to study the prevalence and factors associated with self-prescribed STI prophylaxis among HIV PrEP users. Self-prescribing was reported by ~ […]

Read More…

COVID-19 and People living with HIV – Revisited

Impact of HIV infection on COVID-19 clinical outcome   In June 2020, STI shared a podcast describing the first available data about the outcomes of COVID-19 related hospitalisation for people living with HIV (PLWH). We shared some  take-home points:  1) Encourage disclosure of known HIV status on COVID-19 related hospital admittance  2) Encourage HIV testing […]

Read More…

Highlights of the August 2021 issue

  Editor’s Choice: – Ways to improve knowledge of HIV and STIs among young MSM Why does it matter? Young MSM are at risk of HIV and STIs and poor knowledge is one recognised determinant. Researchers in Ireland tell us that knowledge regarding HIV and STI transmission, testing and treatment among MSM is modulated by […]

Read More…

World Hepatitis Day 2021

STI World Hepatitis Day Podcast In the last decade, direct-acting antivirals have revolutionised hepatitis C treatment. With curative rates in excess of 90%, in 2016 the World Health Organization (WHO) announced the ambitious target of international hepatitis C virus elimination by 2030, aiming to prevent the estimated 400,000 people who die each year from HCV-related […]

Read More…

HPV Vaccine Uptake: Challenges and Opportunities

  Welcome to the fourth episode of the STI BMJ 2021 Podcast series. Please join Dr. Fabiola Martin in interviewing Professors Anna Maria Geretti, Carlo Giaquinto, and Ian Frazer about human papillomavirus vaccines and vaccination programmes. The first HPV vaccine was approved in 2006. Fifteen years later, more than 100 countries have added the vaccine […]

Read More…

COVID-19 Vaccine and People with HIV

  Welcome to the third episode of the 2021 BMJ STI podcast series! As you listen to this podcast, globally thousands of people will receive a dose of SARS-CoV-2 vaccine along with hope for the future. In this podcast, we will explore the main classes of COVID-19 vaccine and issues pertinent to the administration of […]

Read More…

HIV epidemic in Indonesia: Are we there yet?

In this the second STI podcast of 2021, we focus on the HIV epidemic in Indonesia and how the country strives to meet the UNAIDS 90-90-90 UNAIDS sustainability goals for people living with HIV (PLWH). Episode Highlights: Indonesia is a densely populated country spread over 17,000 islands of stunning beauty. It has one of the […]

Read More…